Skip to content

GORE ACUSEAL Vascular Graft ECH470045ARecalls & reported problems

W. L. Gore & Associates, Inc. · GORE ACUSEAL VASCULAR GRAFT 4-7mmX45cm Tapered Heparin · Class 2 · Implant

All models of GORE ACUSEAL Vascular Graft (6)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00733132626984), received between Feb 8, 2022 and Aug 11, 2025 — classified as 3 injuries.

The most frequently reported specific device problem is “Complete Blockage” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Complete Blockage1
  • Peeled/Delaminated1

Patient problems

  • Hematoma1
  • Insufficient Information1
  • Thrombosis/Thrombus1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 11, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2025, A DIALYSIS PATIENT WAS IMPLANTED WITH A GORE® ACUSEAL VASCULAR GRAFT (ACUSEAL VG) FOR DIALYSIS ACCESS IN THE RIGHT FOREARM. ON (B)(6) 2025, THE PATIENT PRESENTED WITH A LARGE HEMATOMA AT THE IMPLANT LOCATION. THE EDEMA INVOLVING THE EPIDERMIS WAS DRAINED. AS REPORTED, THE ACUSEAL VG HAD NOT BEEN CANNULATED. THE PHYSICIAN STATED THE PATIENT APPEARS TO HAVE DEVELOPED AN ALLERGIC REACTION. THE PATIENT DOES NOT HAVE HIT TYPE 2 OR ANY KNOWN ALLERGIES. AN UPDATE WAS PROVIDED ON (B)(6) 2025. IT WAS REPORTED THE CONDITION OF THE PATIENT'S ARM HAS GREATLY IMPROVED, WITH SOME REMAINING EDEMA. THERE ARE NO PLANS FOR ADDITIONAL INTERVENTION OR GRAFT EXPLANT.

    Patient problems: Hematoma

    MAUDE report 22772139 ↗
  • InjuryMar 12, 2025Complete Blockage; Complete Blockage

    THE FOLLOWING WAS REPORTED TO GORE: A PATIENT PRESENTED FOR AN ARTERIOVENOUS (A-V) ACCESS REVISION IN THE LEFT UPPER ARM. AS REPORTED, AN A-V GRAFT LOOP (GORE® ACUSEAL VASCULAR GRAFT) WAS IMPLANTED ON (B)(6) 2025. NOW THE LOOP GRAFT HAD CLOTTED AND REQUIRED AN OPEN THROMBECTOMY. FISTULAGRAM ON BOTH ARTERIAL AND VENOUS ANASTOMOSIS REVEALED SIGNIFICANT STENOSIS TO THE VENOUS OUTFLOW THAT REQUIRED STENTING. ON (B)(6) 2025, AN 8FR X 10CM BRITE TIP SHEATH WAS USED TO ADVANCE THE GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE (VIABAHN DEVICE) TO THE INTENDED TREATMENT SITE. THE VIABAHN DEVICE WAS PLACED AND DEPLOYED FINE. AS THE DELIVERY CATHETER WAS WITHDRAWN, THE DISTAL TIP CAUGHT ON THE EDGE OF THE SHEATH. IT WAS REPORTED THE DISTAL TIP CAME OFF. THE PHYSICIAN WAS ABLE TO RETRIEVE THE DISTAL TIP ALONG WITH THE SHEATH REMOVAL. THE PATIENT DID NOT EXPERIENCE ANY ADVERSE CONSEQUENCES.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 21589085 ↗
  • InjuryFeb 8, 2022Peeled/Delaminated; Peeled/Delaminated

    THE FOLLOWING WAS REPORTED TO GORE: ON AN UNKNOWN DATE, A PATIENT UNDERWENT REVISION OF AN AV FISTULA INVOLVING A GORE® ACUSEAL VASCULAR GRAFT THAT HAD BEEN IMPLANTED IN (B)(6) 2019. IT WAS REPORTED THAT THERE WAS POSSIBLE DELAMINATION. MORE INFORMATION HAS BEEN REQUESTED, BUT HAS NOT BEEN MADE AVAILABLE.

    Patient problems: Insufficient Information

    MAUDE report 13479724 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page